Related Experiment Videos
Acetaminophen and experimental acute myocardial infarction
Sharon L Hale1, Robert A Kloner
1The Heart Institute of Good Samaritan Hospital, and the University of Southern California, Department of Medicine, Division of Cardiovascular Medicine, Los Angeles, CA 90017, USA. sharon.hale@attglobal.net
Cardiovascular Drugs and Therapy
|May 27, 2004
Summary
Acetaminophen did not alter infarct size or blood flow in a rabbit model of myocardial infarction. This study found acetaminophen to have a neutral effect in experimental ischemia/reperfusion, suggesting safety in heart attack models.
Area of Science:
- Cardiology
- Pharmacology
- Experimental Medicine
Background:
- Acetaminophen is a common analgesic with potential benefits in ischemic heart conditions.
- Previous research suggests acetaminophen may positively impact myocardial ischemia.
Purpose of the Study:
- To investigate the effects of acetaminophen on infarct size, myocardial blood flow, and the no-reflow phenomenon.
- To evaluate acetaminophen's impact in a rabbit model of coronary artery occlusion and reperfusion.
Main Methods:
- Rabbits were divided into four groups receiving acetaminophen or vehicle before or after coronary artery occlusion (CAO).
- The study involved 30 minutes of CAO followed by 3 hours of reperfusion.
- Measurements included infarct size, regional myocardial blood flow, and the "no-reflow" phenomenon.
Main Results:
- Acetaminophen administration did not significantly affect infarct size compared to vehicle groups.
- Regional myocardial blood flow remained consistent across all groups during occlusion and reperfusion.
- The "no-reflow" phenomenon was not altered by acetaminophen treatment.
Conclusions:
- Acetaminophen demonstrated a neutral effect in this experimental model of myocardial ischemia/reperfusion.
- The findings suggest acetaminophen is safe for use in experimental models of myocardial infarction.